Table 2. Analysis for Articles of Chinese

First Author (Year) C* & T Samples Treatment Methods Treatment Period Scale Efficacy Evaluation Criteria Mean ㏈ before → after Outcome & P value Side Effects
Tang6) (2017) C : 30 - Vasodilator : Kaishi- Vitamin : B1, B12 14days 1) Curative effect index(CEI)2) Symptom score(deafness, tinnitus, dizzness)3) Hemorheology(Blood coagulation time) CEI-Healing: 95%≤symptom score reduction-Significant effective: 70%≤symptom score reduction<95%;-Effective: 30%≤symptom score<70%-Ineffective: symptom product reduction<30%*Symptom : deafness, tinnitus, dizzness (43.84±12.11)㏈NR CEIC : 66.7%T : 86.7%(p<0.05) NR
T : 30 - HM(OA§) bid with C (40.39±10.57)㏈NR
Wang7) (2017) C : 35 - Vasodilator : Alprostadil- Vitamin : Mecobalamin, Niacin 14days 1) TER2) PTA**2) Total symptom scores(tinnitus, dizziness, ear fullness) TER-Healing: normal hearing-Significantly effective: PTA is increased by more than 30㏈-Effective: PTA is increased by 15-30㏈-Ineffective: PTA is increased by less than 15㏈ (70.5±19.6)㏈(62.2±21.2)㏈ TERC : 71.4%T : 91.7%(p<0.05) NR
T : 35 - HM(OA) bid (71.2±20.3)㏈(50.6±19.4)㏈
Lian8) (2017) C : 33 - Blood Circulating Agent : Ginkgo biloba capsule- Vitamin : Methylcobalamin 14days 1) TER2) PTA3) Total symptom percent(tinnitus, dizziness, ear fullness) TER-Healing: PTA returns to normal, or reaches the level of healty ear, or reaches the level before the illness.-Significant effecttive: PTA is improved by more than 30㏈.-Effective: PTA is improved by 15-29㏈-Ineffective: PTA is improved by less than 14㏈ (56.4±14.57)㏈(35.75±20.61)㏈ TERC : 33.33%T : 84.85%(p<0.05) NR
T : 33 - HM(OA) bid (58.26±16.21)㏈(49.32±22.73)㏈
Zhao9) (2018) C : 82 - Vitamin : Methylcobalamin- Corticosteroid : Dexamethasone- Vasoactive drug : Buflomedil 15days 1) TER2) PTA NR (63.29±17.37)㏈(40.24±15.61)㏈ TERC : 82.72%T : 98.78%(p<0.05) NR
T : 81 - HM(OA) qd with C (63.24±17.36)㏈(31.47±14.55)㏈
Yao10) (2018) B : 50 - Corticosteroid : Dexamethasone- Anti-vertigo medication : Betahistine- Vitamin : mecobalamin, B1 14days 1) TER TER-Healing: normal PTA at 250-4,000㎐, hearing is restored to before the illness, and symptoms disappear.-Effective: PTA at 50-4000㎐ is improved by more than 15㏈, and symptoms are improved.-Ineffective: Symptoms are not relieved or even worsened.*Symptom : tinnitus, dizziness NR TERB : 78.0%A : 96.0%(p<0.05) B : 18.0%A : 4.0%(p<0.05)
A : 50 - HM(OA) bid with B NR
Tian11) (2018) C : 30 - Anti-vertigo medication : Betahistine- Blood Circulating Agent : Shuxuening 28days 1) TER2) Disease socres(deafness, tinnitus, dizziness) TER-Healing: Symptoms return to normal, and disease scores are reduced by 90% or more than before treatment.-Significantly effective: Symptoms return to normal , and disease scores are reduced by 70-89%.-Effective: Symptoms have improved, and symptom score is reduced by 30-69%.-Ineffective: Does not meet the above requirements.*Symptoms : deafness, tinnitus, dizziness NR TERC : 76.67%T : 96.67%(p<0.05) Not serious side effect
T : 30 - HM(OA) bid with C NR
Xue12) (2018) C : 38 - Corticosteroid : Dexamethasone - Coenzyme : Coenzyme A 14days 1) TER2) Hemorheology(Whole blood viscosity) TER-Healing: Symptoms disappear completely, and PTA is completely restored.-Significantly effective: Symptoms have basically disappeared, and PTA is improved by more than 30㏈.-Effective: Symptoms have improved, and P is improved by 15-30㏈.-Ineffective: No relief of clinical symptoms, even serious.*Symptoms : tinnitus, dizziness, nausea, vomiting, nystagmus NR TERC : 78.95%T : 97.37%(p<0.05) Not serious side effect
T : 38 - HM(OA) bid with C NR
Ye13) (2019) C : 30 - Blood Circulating Agent : Ginkgo biloba extract tablets, Citicoline sodium tablets- Anti-vertigo medication : Betahistine, Flunarizine capsules- Corticosteroid : Dexamethasone(Injection intratympanic) 14days 1) TER2) PTA3) Symptoms(tinnitus, dizziness, ear fullness) TER-Healing: Symptoms disappeared, PTA returned to normal.-Significant effective: Symptoms basically disappeared, PTA is improved by more than 30㏈.-Effective: Symptoms improved, PTA is increased by 15-30㏈-Ineffective: No significant change*Symptoms : tinnitus, dizziness, ear fullness (67.03±15.61)㏈(49.23±21.61)㏈ TERC : 63.33%T : 76.67%(p>0.05) NR
T : 30 - HM(OA) bid with C (67.80±15.02)㏈(46.17±21.47)㏈
Lai14) (2019) C : 50 - Vasodilators- Hormonal drugs 14days 1) TER TER-Healing: normal hearing, normal PTA, tinnitus and dizziness disappear.-Effective: PTA is improved by more than 30㏈, tinnitus and dizziness are alleviated, and sleep is not affected.-Ineffective: PTA is increased by less than 15㏈, tinnitus and dizziness are not improved, which affects sleep NR TERC : 84.0%T : 96.0%(p<0.05) Not serious side effect
T : 50 - HM(OA) bid with C NR
Jiang15) (2019) C : 30 - Vasodilators : Vinpocetine 10days 1) TER2) PTA3) Dizziness TER-Healing: PTA at 0.25-4k㎐ returns to the normal level or reaches the level before the illness.-Significant effective: PTA at 0.25-4k㎐ is improved by more than 30㏈.-Effective: PTA at 0.25-4k㎐ is improved by 15-30㏈.-Invalid: PTA at 0.25-4k㎐ is improved by less than 15㏈. (62.46±9.64)㏈(52.16±8.02)㏈ TERC : 50.0%T : 66.7%(p<0.05) NR
T : 30 - HM(OA) bid with C (63.25±8.86)㏈(45.71±8.17)㏈
Wang16) (2019) C : 70 - Corticosteroid : Methylprednisolone(Injection. skin behind the ears) 14days 1) TER2) PTA3) Hemorheology(plasma viscosity, blood coagulation time, hematocrit, Homocysteine) TER-Healing: noraml PTA or reaches the level of the healthy ear-Significantly effect: PTA is improved by more than 30㏈.-Effective: PTA is improved by 15-30㏈.-Ineffective: PTA is improved by less than 15㏈. (73.48±9.70)㏈(41.37±7.65)㏈ TERC : 78.57%T : 85.71%(p<0.05) C : 11.43%T : 4.29%(p>0.05)
T : 70 - HM(OA) bid with C (74.53±8.96)㏈(33.61±6.42)㏈
Chen17) (2020) C : 41 - Corticosteroid : Prednisone acetate tablets- Vasodilator : Alprostadil 10days 1) TER2) PTA3) Deafness4) Total symptoms scores(deafness, tinnitus, ear fullness, dark red lips) TER-Healing: Symptoms disappeared, impaired PTA returned to normal.-Significant effective: Symptoms basically disappeared, PTA is improved by more than 30㏈.-Effective: Symptoms improved, PTA is increased by 15-30㏈-Ineffective: No significant change*Symptoms : deafness, tinnitus, ear fullness, dark red lips (65.12±8.31)㏈(48.28±7.62)㏈ TERC : 73.2%T : 90.2%(p<0.05) NR
T : 41 - HM(OA) bid with C (67.32±8.23)㏈(41.61±5.37)㏈
Qi18) (2020) C : 34 - Vitamin : Mecobalamin vitamin C- Vasodilator : Alprostadil- Corticosteroid : Dexamethasone 14days 1) TER2) PTA3) Hemorheology(plasma viscosity, fibrinogen, hematocrit) TER-Healing: normal PTA, or returns to the level of the uninfected side, or the level before the illness.-Significant effective: PTA is improved by more than 30㏈.-Effective: PTA is improved by 15-30㏈.-Ineffective: PTA is improved by less than 15㏈. (63.25±10.48)㏈(40.53±8.14)㏈ TERC : 70.59%T : 91.18%(p<0.05) C : 17.65%T : 14.71%(p>0.05)
T : 34 - HM(OA) bid with C (63.14±10.29)㏈(48.75±9.26)㏈
Fu19) (2020) C : 43 - Vasodilator : Alprostadil- Nerve growth factor 14days 1) TER2) Hemorheology(whole blood viscosity, plasma viscosity, fibrinogen, hematocrit)3) Total symptoms scores(deafness, tinnitus, dizziness, dark red tongue, petechia) TER-Healing: PTA returns to normal or healthy ears or before the onset, the syndrome score reduction is greater than 90%.-Significant effective: PTA is increased by more than 30㏈, and the syndrome score is reduced by 60% to 89%.-Effective: PTA is increased by 15-29㏈, and the syndrome score decreases by 30% to 59%.-Ineffective: PTA did’t increase significantly, and the syndrome score decreased by less than 29%.*Symptoms : deafness, tinnitus, dizziness, dark red tongue, petechia NR TERC : 72.09%T : 93.18%(p<0.05) NR
T : 44 - HM(OA) bid with C NR
Sun20) (2020) C : 37 - Corticosteroid : Prednisone- Vasodilator : Alprostadil- Vitamin : Mecobalamin 14days 1) TER2) PTA3) Plasma lipids4) Atherogenic index of plasma TER-Healing: normal hearing-Significantly effective: PTA is increased by more than 30㏈.-Effective: PTA is increased by 15-30㏈.-Ineffective: PTA is increased by less than 15㏈ (62.43±11.88)㏈(49.08±14.71)㏈ TERC : 67.50%T : 78.05%(p<0.05) NR
T : 37 - HM(OA) bid with C (63.37±10.82)㏈(40.54±13.70)㏈
Guo21) (2020) C : 44 - Vasodilator : Alprostadil- Vitamin : Mecobalamin, Niacin 14days 1) TER2) PTA3) Symptom score(deafness, tinnitus, dizzness) TER-Healing: Symptoms disappear, and PTA returns to normal-Effective: Symptoms are improved, PTA is increased by more than 15㏈-Ineffective: Inconsistent with the above description. (72.94±14.77)㏈(62.02±15.92)㏈ TERC : 75.00%T : 95.45%(p<0.05) NR
T : 44 - HM(OA) bid (73.22±12.08)㏈(50.25±16.24)㏈
Lin22) (2020) C : 30 - Vitamin : Methylcobalamin- Blood Circulating Agent : Ginkgo biloba extract- Corticosteroid : Methylprednisolone 10-14days 1) TER2) PTA3) Symptom score( tinnitus, dizzness, ear fullness) TER-Healing: PTA returns to normal, or reaches the level of healty ear, or reaches the level before the illness.-Significantly effective: PTA is improved by more than 30㏈.-Effective: PTA is improved by 15-30㏈.-Ineffective: PTA is improved by less than 15㏈. (55.23±15.61)㏈(38.47±18.35)㏈ TERC : 60.0%T : 79.49%(p<0.05) NR
T : 78 - HM(OA) with C (54.64±12.73)㏈(33.18±13.55)㏈
Zhao23) (2020) C : 60 - Corticosteroid : Dexamethasone- Blood Circulating Agent : Troxerutin cerebroprotein hydrolysate- Nerve growth factor 14days 1) TER2) Tinnitus TER-Healing: normal hearing or reaches the level before the illness-Significantly effective: PTA is improved by more than 30㏈.-Effective: PTA is improved by 15-30㏈.-Ineffective: PTA is improved by less than 15㏈. NR TERC : 66.66%T : 90.0%(p<0.05) C : 6.67%T : 13.34%(p>0.05)
T : 60 - HM(OA) bid with C NR
Dong24) (2021) C : 30 - Corticosteroid : Dexamethasone(injecion IV & intratympanic)- Blood Circulating Agent : Troxerutin cerebroprotein hydrolysate, Shuxuening- Nerve growth factor 14days 1) TER2) Symptom score(dizziness, tinnitus, deafness) TER-Healing: PTA at 0.5-4k㎐ reaches normal, or to the hearing value of healthy ears, or to the hearing value before illness-Significant effective: PTA at 0.5-4k㎐ is improved by more than 30㏈-Effective: PTA is improved by 15-30㏈-Ineffective: PTA is improved by less than 15㏈. NR TERC : 63.33%T : 86.67%(p<0.05) NR
T : 30 - HM(OA) bid with C NR
Huang25) (2021) C : 31 - Corticosteroid : Prednisone- Viatamin : Mecobalamin- Blood Circulating Agent : Ginkgo biloba extract 14days 1) TER2) PTA3) Hemorheology(Fibrinogen, Plasma viscosity, whole blood viscosity)4) Symptoms score(ear fullness, tinnitus, dizziness, nausea<vomiting) TER-Significantly effective: symptoms disappeared or syndrome scores are reduced by more than 70%, and normal hearing.-Effective: symptoms are significantly improved, syndrome scores are reduced by more than 50%, PTA is improved by more than 15㏈-Ineffective: PTA is improved less than 15㏈, symptoms are not improved or even worse.*Symptom : ear fullness, tinnitus, dizziness, nausea, vomiting (64.33±8.65)㏈(44.37±5.77)㏈ TERC : 74.19%T : 96.77%(p<0.05) C : 12.90%T : 6.45%(p>0.05)
T : 31 - HM(OA) hs with C (64.27±8.76)㏈(39.74±5.82)㏈
Pan26) (2021) C : 36 - Vasodilators- Nerve nutrition- Anticoagulation- Corticosteroid 14days 1) TER2) PTA TER-Healing: normal hearing, symptoms disappear-Significant effective: PTA is increased by more than 30㏈, symptoms are significantly reduced.-Effective: PTA is increased by 15-30㏈, symptoms are reduced.-Ineffective: Does not meet the above criteria (63.78±9.61)㏈(42.23±6.65)㏈ TERC : 76.7%T : 95.1%(p<0.05) TERC : 16.77%T : 11.1%(p>0.05)
T : 36 - HM(OA) bid with C (62.05±8.63)㏈(31.17±4.13)㏈
Xia27) (2021) C : 40 - Corticosteroid : Dexamethasone NR 1) TER2) Symptom(tinnitus, deafness, ear fullness) TER-Healing: PTA returns to the normal level, or reaches the level of healthy ear, or reaches the level before the illness.-Significantly effective: PTA is improved by more than 30㏈.-Effective: PTA is improved by 15-30㏈.-Ineffective: PTA is improved by less than 15㏈. NR PTAC : 72.5%T : 87.5%(p<0.05) NR
T : 40 - HM(OA) with C NR
C : Control
T : Treatment
HM : Herbal Medicine
OA : Oral Administraion
NR : No Reported
TER : Total effective rate
PTA : Pure Tone Audiometry